Kelix bio
Healthcare
09 May, 2024
Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal
Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based pharma entities to further expand ......
Healthcare
26 March, 2024
Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others
Abu Dhabi’s sovereign investor Mubadala Investment Company, which manages assets worth $276 billion in more than 50 countries, is set ......
Healthcare
16 January, 2025
Kelix bio makes fifth strategic deal since acquisition by Mubadala
Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News